Related references
Note: Only part of the references are listed.Mast cell tryptase - Marker and maker of cardiovascular diseases
Mohammad Mohajeri et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Is Interleukin-38 a key player cytokine in atherosclerosis immune gene therapy?
Abdolreza Esmaeilzadeh et al.
MEDICAL HYPOTHESES (2019)
Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
Eva Kritikou et al.
CELLS (2019)
Divergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions
Elin Ronnberg et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-33/IL-33R in various types of carotid artery atherosclerotic lesions
Milos Stankovic et al.
CYTOKINE (2019)
Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions
Petri T. Kovanen
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mast cellsGood guys with a bad image?
Nicole Meyer et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)
Improvement of endothelial function by pitavastatin: a meta-analysis
Niki Katsiki et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
IL-33/IL-31 Axis: A Potential Inflammatory Pathway
Eleonora Di Salvo et al.
MEDIATORS OF INFLAMMATION (2018)
Effect of statins on toll-like receptors: a new insight to pleiotropic effects
Afsane Bahrami et al.
PHARMACOLOGICAL RESEARCH (2018)
Inhibition of the mevalonate pathway by simvastatin interferes with mast cell degranulation by disrupting the interaction between Rab27a and double C2 alpha proteins
Muhammad Novrizal Abdi Sahid et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment
Alkistis Kapelouzou et al.
JOURNAL OF VASCULAR RESEARCH (2017)
Activation-induced upregulation of MMP9 in mast cells is a positive feedback mediator for mast cell activation
Lin Xu et al.
MOLECULAR MEDICINE REPORTS (2017)
Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study
Amela Kabaklic et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
Statins, haemostatic factors and thrombotic risk
Vanessa Bianconi et al.
CURRENT OPINION IN CARDIOLOGY (2017)
Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets
Nynke A. Jager et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
Piotr Chrusciel et al.
ATHEROSCLEROSIS (2016)
Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials
Amirhossein Sahebkar et al.
AUTOIMMUNITY REVIEWS (2016)
Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis
Giuseppe Derosa et al.
DRUGS (2016)
The impact of mast cells on cardiovascular diseases
Eva Kritikou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects
Elizabeth Motunrayo Kolawole et al.
JOURNAL OF IMMUNOLOGY (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials
Amirhossein Sahebkar et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1 A systematic review and meta-analysis of randomised controlled trials
Amirhossein Sahebkar et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Mast Cell: A Multi-Functional Master Cell
Melissa Krystel-Whittemore et al.
FRONTIERS IN IMMUNOLOGY (2016)
Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression
Anouk Wezel et al.
ATHEROSCLEROSIS (2015)
Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials
Amirhossein Sahebkar et al.
ATHEROSCLEROSIS (2015)
The role of IL-33/ST2L signals in the immune cells
Jingli Lu et al.
IMMUNOLOGY LETTERS (2015)
Association between statin use and plasma D-dimer levels
Amirhossein Sahebkar et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability
Daiane Silvello et al.
BIOMARKERS (2014)
Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
Mira Katan et al.
PLOS ONE (2014)
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
Behzad Yeganeh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Mast cell secretory granules: armed for battle
Sara Wernersson et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Ion channels regulating mast cell biology
I. Ashmole et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
Effect of atorvastatin on expression of TLR4 and NF- κ B p65 in atherosclerotic rabbits
Ding-Zhu Shen et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2013)
Cardiovascular Disease in the Developing World
David S. Celermajer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
TLR signaling in mast cells: common and unique features
Hilary Sandig et al.
FRONTIERS IN IMMUNOLOGY (2012)
Accessory molecules for Toll-like receptors and their function
Clarissa C. Lee et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Plaque Rupture is a Determinant of Vascular Events in Carotid Artery Atherosclerotic Disease: Involvement of Matrix Metalloproteinases 2 and 9
Sung Hyuk Heo et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
Simvastatin Therapy Reduces Prooxidant-Antioxidant Balance: Results of a Placebo-Controlled Cross-Over Trial
Seyyed M. R. Parizadeh et al.
LIPIDS (2011)
Toll like receptor 4 in atherosclerosis and plaque destabilization
Wijnand K. den Dekker et al.
ATHEROSCLEROSIS (2010)
Phospholipase A(2) inhibitors as potential therapeutic agents for the treatment of inflammatory diseases
Victoria Magrioti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
IgE, mast cells, basophils, and eosinophils
Kelly D. Stone et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation
Chia-Lin Hsu et al.
PLOS ONE (2010)
Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level
Masanori Fujimoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
TLR-4, IL-1R and TNF-R signaling to NF-kappa B: variations on a common theme
L. Verstrepen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells
Shin-ichiro Kagami et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan
Maria Ringvall et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Molecular Imaging of Matrix Metalloproteinase in Atherosclerotic Lesions
Shinichiro Fujimoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells
David Moulin et al.
CYTOKINE (2007)
The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4
Srie Prihianti Gondokaryono et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Mast cells promote atherosclerosis by releasing proinflammatory cytokines
Jiusong Sun et al.
NATURE MEDICINE (2007)
Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice
Ilze Bot et al.
CIRCULATION (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Mast cells: Not only in allergy
Ido Bachelet et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells
MT Krauth et al.
ALLERGY (2006)
Anti-angiogenic and anti-inflammatory effects of statins:: Relevance to anti-cancer therapy
J Dulak et al.
CURRENT CANCER DRUG TARGETS (2005)
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
MA Albert et al.
ATHEROSCLEROSIS (2005)
Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components
J Talreja et al.
IMMUNOLOGY (2004)
Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease
G Pasterkamp et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils
SR Li et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB
V Tsimihodimos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Share Paper
